Skip to content

The safety and clinical efficacy of ultrasound-guided acupotomy therapy for carpal tunnel syndrome

The safety and clinical efficacy of ultrasound-guided acupotomy therapy for carpal tunnel syndrome

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082124
Enrollment
Unknown
Registered
2024-03-21
Start date
2023-06-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome

Interventions

Visual group:The blind trial group was treated with traditional needle-knife therapy, and the visualization group was guided by ultrasound. The clinical efficacy, complication rate, VAS value, Michiga
Blind group:The blind trial group was treated with traditional needle-knife therapy, and the visualization group was guided by ultrasound. The clinical efficacy, complication rate, VAS value, Michigan

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for carpal tunnel syndrome. 2. Age between 18 and 65 years old, regardless of gender. 3. Chronic onset, course of disease within 1 month -2 years. 4. Give informed consent and volunteer for the test. The process of obtaining informed consent shall comply with GCP regulations.

Exclusion criteria

Exclusion criteria: 1. Does not meet the above diagnostic criteria and inclusion criteria; 2. Patients with severe carpal tunnel syndrome who have shown signs of surgical treatment; 3. Severe visceral disease and severe heart, liver and kidney damage: 4. Patients with severe osteoporosis, bone tuberculosis and advanced tumors; 5. Patients with severe diabetes and drug allergies (such as triamcinolone and lidocaine); 6. Spontaneous bleeding tendency and coagulation dysfunction (such as hemophilia, thrombocytopenia); 7. People who are taking or long-term taking anticoagulant drugs (such as aspirin); 8. Is receiving other related treatment, which may affect the observational indicators of this study; 9. Patients who cannot cooperate with acupotomy treatment; 10. Psychopaths and severe cognitive dysfunction are not suitable for the author.

Design outcomes

Primary

MeasureTime frame
Clinical effect;Visual analogue scale, VAS;Michigan score;

Secondary

MeasureTime frame
Electrophysiological index;Ultrasonic imaging;Changes in the thickness of the transverse ligament of the wrist;

Countries

CHINA

Contacts

Public ContactHe Ningning

Jiangsu Province Hospital of TCM

506092567@qq.com+86 152 9551 9657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026